SARS-CoV-2 Infection in Patients with Cystic Fibrosis: What We Know So Far

被引:5
|
作者
Biondo, Carmelo [1 ]
Midiri, Angelina [1 ]
Gerace, Elisabetta [2 ]
Zummo, Sebastiana [1 ]
Mancuso, Giuseppe [1 ]
机构
[1] Univ Messina, Dept Human Pathol, I-98125 Messina, Italy
[2] ASP Azienda Sanit Prov, I-90141 Palermo, Italy
来源
LIFE-BASEL | 2022年 / 12卷 / 12期
关键词
cystic fibrosis; viral infections; COVID-19; CLINICAL CHARACTERISTICS; INNATE IMMUNITY; COVID-19; CORONAVIRUS; CHILDREN; PEOPLE; IMPACT; DISEASE;
D O I
10.3390/life12122087
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Respiratory infections are the most common and most frequent diseases, especially in children and the elderly, characterized by a clear seasonality and with an incidence that usually tends to decrease with increasing age. These infections often resolve spontaneously, usually without the need for antibiotic treatment and/or with the possible use of symptomatic treatments aimed at reducing overproduction of mucus and decreasing coughing. However, when these infections occur in patients with weakened immune systems and/or underlying health conditions, their impact can become dramatic and in some cases life threatening. The rapid worldwide spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection has caused concern for everyone, becoming especially important for individuals with underlying lung diseases, such as CF patients, who have always paid close attention to implementing protective strategies to avoid infection. However, adult and pediatric CF patients contract coronavirus infection like everyone else. In addition, although numerous studies were published during the first wave of the pandemic on the risk for patients with cystic fibrosis (CF) to develop severe manifestations when infected with SARS-CoV-2, to date, a high risk has been found only for patients with poorer lung function and post-transplant status. In terms of preventive measures, vaccination remains key. The best protection for these patients is to strengthen preventive measures, such as social distancing and the use of masks. In this review, we aim to summarize and discuss recent advances in understanding the susceptibility of CF individuals to SARS-CoV-2 infection.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] SARS-CoV-2; What We Know so far
    Rajani, Huda Fatima
    Alshaikh, Fatima Ahmed
    Anushiravani, Amir
    [J]. ARCHIVES OF IRANIAN MEDICINE, 2020, 23 (07) : 498 - 502
  • [2] SARS-CoV-2 Infection in Neonate: What do We Know So Far?
    Moscoso, Joana
    Marcal, Monica
    Tuna, Madalena
    [J]. ACTA MEDICA PORTUGUESA, 2020, 33 (06): : 444 - 444
  • [3] SARS-CoV-2: What do we know so far?
    Khedkar, Pratik H.
    Patzak, Andreas
    [J]. ACTA PHYSIOLOGICA, 2020, 229 (02)
  • [4] SARS-CoV-2 Related Myocarditis: What We Know So Far
    Mistrulli, Raffaella
    Ferrera, Armando
    Muthukkattil, Melwyn Luis
    Volpe, Massimo
    Barbato, Emanuele
    Battistoni, Allegra
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (14)
  • [5] Intrauterine vertical transmission of SARS-CoV-2: what we know so far
    Wang, C.
    Zhou, Y. -H.
    Yang, H. -X.
    Poon, L. C.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2020, 55 (06) : 724 - 725
  • [6] Genetic Variants of SARS-CoV-2: What Do We Know So Far?
    Jamil, Shazia
    Shafazand, Shirin
    Pasnick, Susan
    Carlos, W. Graham
    Maves, Ryan
    Dela Cruz, Charles
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (12) : P30 - P32
  • [7] The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
    Chavda, Vivek P.
    Bezbaruah, Rajashri
    Deka, Kangkan
    Nongrang, Lawandashisha
    Kalita, Tutumoni
    [J]. VACCINES, 2022, 10 (11)
  • [8] SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far
    Rabi, Firas A.
    Al Zoubi, Mazhar S.
    Kasasbeh, Ghena A.
    Salameh, Dunia M.
    Al-Nasser, Amjad D.
    [J]. PATHOGENS, 2020, 9 (03):
  • [9] Chronic Obstructive Pulmonary Disease and SARS-CoV-2 Infection. What Do We Know so Far?
    Figueira Goncalves, Juan Marco
    Golpe, Rafael
    Garcia-Talavera, Ignacio
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 : 5 - 6
  • [10] Lessons from SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections: What We Know So Far
    Alsafi, Radi Taha
    [J]. CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2022, 2022